Compile Data Set for Download or QSAR
maximum 50k data
Found 117 of ic50 for UniProtKB: A0A024R2Q3
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396286(US10314832, Compound 2)
Affinity DataIC50:  13nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396284(US10314832, Compound 1)
Affinity DataIC50:  28.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396287(US10314832, Compound 3)
Affinity DataIC50:  38.5nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396292(US10314832, Compound 8)
Affinity DataIC50:  83nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396291(US10314832, Compound 7)
Affinity DataIC50:  183nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50:  805nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396289(US10314832, Compound 5)
Affinity DataIC50:  1.27E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396298(US10314832, Compound 15)
Affinity DataIC50:  1.39E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509812(CHEMBL4548532)
Affinity DataIC50:  1.70E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50589223(CHEMBL5185515)
Affinity DataIC50:  2.00E+3nMAssay Description:Inhibition of human recombinant GST tagged beta catenin ARD by Alphascreen assayMore data for this Ligand-Target Pair
In DepthDetails PubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396290(US10314832, Compound 6)
Affinity DataIC50:  2.10E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509813(CHEMBL4451478)
Affinity DataIC50:  2.50E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396299(US10314832, Compound 16)
Affinity DataIC50:  2.57E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396302(US10314832, Compound 19)
Affinity DataIC50:  3.90E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50436054(CHEMBL2397077)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of beta-catenin-mediated transcriptional activity in Wnt3a-stimulated human HeLa cells after 24 hrs by Dual-Glo luciferase reporter gene a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50436055(CHEMBL2397076)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of beta-catenin-mediated transcriptional activity in Wnt3a-stimulated human HeLa cells after 24 hrs by Dual-Glo luciferase reporter gene a...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509810(CHEMBL4464142)
Affinity DataIC50:  5.90E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396301(US10314832, Compound 18)
Affinity DataIC50:  6.00E+3nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50014148(CHEMBL3260853)
Affinity DataIC50:  6.30E+3nMAssay Description:Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509801(CHEMBL4464433)
Affinity DataIC50:  7.30E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509781(CHEMBL4450852)
Affinity DataIC50:  7.50E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509803(CHEMBL4449577)
Affinity DataIC50:  8.50E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509802(CHEMBL4515157)
Affinity DataIC50:  8.90E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509818(CHEMBL4579221)
Affinity DataIC50:  9.30E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509819(CHEMBL4460073)
Affinity DataIC50:  9.80E+3nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509817(CHEMBL4565782)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509804(CHEMBL4455488)
Affinity DataIC50:  1.00E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396293(US10314832, Compound 9)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396297(US10314832, Compound 14)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396294(US10314832, Compound 10)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396296(US10314832, Compound 12)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396300(US10314832, Compound 17)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM396288(US10314832, Compound 11 | US10314832, Compound 4)
Affinity DataIC50: >1.00E+4nMAssay Description:Compounds that enhance the Wnt activity, or Activators, were assayed as follows. Reporter cell lines were generated by stably transducing cells of ca...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509799(CHEMBL4532791)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509807(CHEMBL4560197)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50577925(CHEMBL4846565)
Affinity DataIC50:  1.10E+4nMAssay Description:Inhibition of beta-catenin (unknown origin) transfected in HEK293 cells cotransfected with pCMV-RL assessed as reduction in luciferase activity measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509829(CHEMBL4456139)
Affinity DataIC50:  1.20E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509796(CHEMBL4535419)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50014132(CHEMBL2323032)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509833(CHEMBL4464915)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509780(CHEMBL4538548)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509798(CHEMBL4515538)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509805(CHEMBL4451874)
Affinity DataIC50:  1.40E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50014148(CHEMBL3260853)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50094490(CHEMBL3589156)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of human wild-type beta-catenin (residues 138-686)/C-terminally fluorescein labeled human wild-type Tcf4 (residues 7-51) interaction after...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509823(CHEMBL4561695)
Affinity DataIC50:  1.60E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50577931(CHEMBL4863751)
Affinity DataIC50:  1.60E+4nMAssay Description:Inhibition of beta-catenin (unknown origin) transfected in HEK293 cells cotransfected with pCMV-RL assessed as reduction in luciferase activity measu...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509827(CHEMBL4544508)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509828(CHEMBL4591545)
Affinity DataIC50:  1.70E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCatenin beta-1(Homo sapiens (Human))
Samumed

US Patent
LigandPNGBDBM50509786(CHEMBL4577989)
Affinity DataIC50:  1.90E+4nMAssay Description:Inhibition of C-terminal fluorescein-labeled human TCF4 (7 to 51 residues) binding to wild-type C-terminal His6-tagged beta-catenin (138 to 781 resid...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 117 total ) | Next | Last >>
Jump to: